Myofibrillar Ca2+ Sensitization Predominantly Enhances Function and Mechanical Efficiency of Stunned Myocardium
Loe Kie Soei, MD; Loes M.A. Sassen, MD; Dong Sheng Fan, MD; Tineke van Veen, MD; Rob Krams, MD; Pieter D. Verdouw, PhD Background Myocardial stunning is characterized not only by a decreased regional postischemic function but also by a relatively high oxygen consumption (ie, decreased mechanical efficiency). Several lines of evidence suggest that the underlying mechanism may involve a decreased sensitivity of the myofibrils to calcium, but in vivo evidence is lacking. We therefore evaluated this hypothesis in vivo using EMD 60263, a calcium-sensitizing agent, which is devoid of any phosphodiesterase-inhibiting properties. Methods and Results We first established the effect of two consecutive doses of EMD 60263 (0.75 and 1.5 mg/kg IV, n=7), administered at 15-minute intervals, on segment length shortening (SLS), external work index (EW; the area inside the left ventricular pressure-segment length loop), myocardial oxygen consumption (MVo2), and mechanical efficiency (EW/ MVo2) in anesthetized pigs with normal myocardium. After the highest dose of EMD 60263, SLS in the distribution area of the left anterior descending coronary artery (LADCA) increased from 13± 1% at baseline to 17± 1% (P<.05). However, EW, MVo2, and EW/MVo2 were not significantly affected (123±10%, 98+9%, and 85±13% of baseline, respectively). In 14 other anesthetized pigs, myocardial stunning was induced by two sequences of 10 minutes of LADCA occlusion and 30 minutes of myocardial reperfusion. After induction of stunning, the two doses of EMD 60263 (n=7) or saline (3 and 6 mL, n=7) were infused. In the distribution area of the LADCA, the stunning protocol caused decreases in SLS from 16±1% to 8±1% (P<.05) and in EW to 49±5% of baseline (P<.05), whereas MVo2 was only minimally affected (P>.05).
Consequently, mechanical efficiency decreased to 59±8% of baseline (P<.05). Saline infusion did not affect any of these regional myocardial variables, but after administration of EMD 60263 SLS recovered dose-dependently to 15±2% after the highest dose of the drug. EW and mechanical efficiency also recovered dose-dependently to 89±4% (P<.05 versus stunning) and to 88±7% (NS versus baseline) of baseline, respectively. In the not-stunned segment, SLS increased from 15±2% (at baseline) to 18±2% (after the highest dose), and EW per beat was not changed significantly. An adrenergic mode of action of EMD 60263 was excluded by blocking the aand f-adrenergic receptors with phentolamine and propranolol, respectively, 15 minutes before administration of EMD 60263 (ie, 15 minutes into the second reperfusion period) in five additional experiments. In these experiments the EMD 60263-induced increases in SLS and EW were not attenuated. Because EMD 60263 decreased heart rate from 106±4 to 76±3 beats per minute (P<.05) in the animals with stunned myocardium, we performed five experiments with the specific negative chronotropic compound zatebradine (UL-FS 49, 0.1 to 0.5 mg/kg) to rule out bradycardia as a factor contributing to the effects of EMD 60263. These zatebradine doses lowered heart rate from 116±5 to 55±1 beats per minute (P<.05) but had no effect on SLS of stunned and not-stunned myocardium.
Conclusions Calcium sensitization affects function and mechanical efficiency of stunned myocardium more profoundly than of not-stunned myocardium, lending support to the hypothesis that Cal' desensitization of the myofibrils is involved in myocardial stunning. (Circulation. 1994;90:959-969.) Key Words * EMD 60263 * systemic hemodynamics * regional myocardial function * myocardial oxygen consumption T he mechanism underlying the prolonged contractile dysfunction after a short period of myocardial ischemia ("myocardial stunning") is still unknown. Proposed hypotheses include a reduced ability to synthesize high-energy phosphates, impairment of regional perfusion, impairment of sympathetic neural responsiveness, generation of free radicals, activation of leukocytes, reduction in the activity of creatine kinase, and disturbances in calcium homeostasis, but most of these mechanisms have been refuted (for review see References 1 and 2). The current view holds that the generation of free radicals and disturbances in the calcium handling of the myocardial cell, mechanisms that are not mutually exclusive, are the two most likely mechanisms that cause this reversible postischemic dysfunction.' Transient calcium overload as found during the early reperfusion phase may lead to disturbances in calcium homeostasis and/or decreased sensitivity of the myofilaments to calcium.3'4 Several groups of investigators have shown that the capacity of cardiac sarcoplasmic reticulum to transport Ca`+ decreases time-dependently during ischemia,5-7 which suggests that a reduced function of the Ca`+ pump might play a role in the mechanism leading to stunning. In a recent study, however, we have shown that in stunned myocardium of intact openchest pigs the phosphorylation state of phospholamban was unchanged, and the Ca`+ uptake by the sarcoplasmic reticulum was even slightly increased,8 whereas H3C EMD 60263 H3CO OCH3 FIG 1. Diagram shows the chemical structure of EMD 60263. regional myocardial contractile function was still severely depressed.9 These data suggest that a change in the active Ca21 transport of the sarcoplasmic reticulum may not be the principal cause of the contractile dysfunction of stunned myocardium. Marban4 and Kusuoka et al'0 found no differences in intracellular Ca21 transients in isolated ferret hearts before and after stunning and therefore concluded that the crucial lesion in stunning occurs at a later stage of the excitationcontraction process, ie, the responsiveness of the myofilaments to calcium.4"10 Until now, in vivo evidence of this hypothesis has been difficult to obtain because agents that possess Ca2+-sensitizing properties, such as AR-L 57,11,12 sulmazole,"314 and pimobendan,1516 increase myocardial contractility predominantly via inhibition of phosphodiesterase and thus by increasing the Ca 2 transient.
In the present study we report on the cardiovascular effects of the thiadiazinone derivative EMD 60263 ( Fig  1) in pigs with stunned myocardium. In in vitro experiments this compound has been shown to be a potent Ca'+ sensitizer devoid of any phosphodiesterase-inhibiting properties (I. Lues, M. Klockow, personal communication, November 1993). The same investigators also demonstrated that in voltage-clamped myocytes the presence of EMD 60263 affected the delayed rectifier current, IKr, in a way that is characteristic for class III antiarrhythmic action. Potassium channel blockade might potentially increase myocardial contractility by increasing the action potential duration and therefore Ca'+ influx. However, this mechanism does not contribute to a positive inotropic effect of EMD 60263, as its enantiomer EMD 60264, which only differs from EMD 60263 because it lacks Ca2+-sensitizing properties, exerts a negative inotropic action (Ravens I, personal communication, November 1993).
In the present study myocardial stunning was induced by two cycles of 10 minutes of coronary artery occlusion separated by 30 minutes of reperfusion. This protocol causes a prolonged depression of regional myocardial function without myocardial necrosis,1718 while Ca21 uptake by the sarcoplasmic reticulum and phosphorylation of phospholamban is not depressed. 8 The effect of EMD 60263 on regional myocardial function was assessed by studying both the systolic segment length shortening (SLS) and external work (EW) performed by the stunned and not-stunned myocardial segments. EW was estimated from the area enclosed by the left ventricular pressure-segment length loop, which has been validated as a reliable index by several groups of investigators.19,20 Because a major characteristic of stunned myocardium is also a relatively high oxygen consumption for the amount of work performed,21'22 a phenomenon that may also point toward a decrease in calcium sensitivity,23 we also evaluated the effect of EMD 60263 on mechanical efficiency, which is the amount of EW performed by the myocardium per unit consumed oxygen.
Methods

Animal Care
All experiments were performed in accordance with the guiding principles in the care and use of animals as approved by the Council of the American Physiological Society and under the regulations of the animal care committee of the Erasmus University Rotterdam (the Netherlands).
Surgical Preparation
After an overnight fast, crossbred Landrace x Yorkshire pigs of either sex (23 to 30 kg, n=31) were sedated with ketamine (20 to 30 mg/kg IM, Apharmo) and anesthetized with sodium pentobarbital (20 mg/kg IV, Sanofi). The animals were intubated and connected to a respirator for intermittent positive pressure ventilation with a mixture of oxygen and nitrogen. Respiratory rate and tidal volume were set to keep arterial blood gases within the normal range: pH between 7.35 and 7.45, Pco0 between 35 and 45 mm Hg, and Po2 between 120 and 180 mm Hg. Catheters were inserted into the superior caval vein for continuous administration of sodium pentobarbital (5 mg/kg per hour) and haemaccel (Behringwerke AG) for replacement of blood withdrawn during sampling. Fluidfilled catheters were positioned in the descending aorta for withdrawal of blood samples and monitoring of central aortic blood pressure. Through the left carotid artery a micromanometer-tipped catheter (B Braun Medical BV) was inserted into the left ventricle for measurement of left ventricular blood pressure and, by electrical differentiation, its first derivative (LVdP/dt). After administration of pancuronium bromide (4 mg, Organon Teknika), a midsternal thoracotomy was performed, and the heart was suspended in a pericardial cradle. An electromagnetic flow probe (Skalar) was placed around the ascending aorta for measurement of aortic blood flow (cardiac output). A proximal segment of the left anterior descending coronary artery (LADCA) was then dissected free for placement of an atraumatic clamp for occlusion of the coronary artery (n=24) or a Doppler flow probe (n=7), and the accompanying vein was cannulated for collection of local coronary venous blood.
Regional myocardial SLS was measured by sonomicrometry (Triton Technology Inc). One pair of the ultrasonic crystals was implanted inside the distribution area of the LADCA and another pair inside the distribution area of the left circumflex coronary artery (LCXCA). The crystals of each pair were positioned in the midmyocardial layer approximately 10 to 15 mm apart.
For determination of regional blood flows, the left atrial appendage was cannulated for injection of a batch of 1 to 2x106 carbonized plastic microspheres (15+1 mm [SD] in diameter) labeled with either 'Sc, 95Nb, 103Ru, 113Sn, or 141Ce (NEN Co). Starting 15 seconds before the injection of microspheres, blood was withdrawn from a femoral artery at a rate of 10 mL/min until 60 to 65 seconds after completion of microsphere injection. At the end of each experiment, the area perfused by the LADCA was identified by ligation of the coronary artery at the site of occlusion and injection of patent blue violet (Sigma Chemical Co) via the left atrial catheter.
The heart and a number of other organs were excised and handled as described previously for determination of regional blood flows.24
Experimental Protocols
After the preparation had remained stable for at least 30 minutes following completion of instrumentation, baseline values were obtained for systemic hemodynamic variables, regional myocardial function, and arterial and coronary venous blood gases. Samples were collected for the measurement of hemoglobin concentration, oxygen saturation, pH, Pco2, and P02.
We first evaluated the effect of two doses of EMD 60263 (0.75 and 1.5 mg/kg, dissolved in 3 and 6 mL saline, respectively) on global systemic hemodynamics, regional systolic SLS, EW, myocardial oxygen consumption (MVo2), and mechanical efficiency in seven animals with a normal intact coronary circulation. Each dose was infused over a 3-minute period, and infusions were separated by a 15-minute interval. In these animals LADCA blood flow was measured with the Doppler flow probe.
In 14 animals a batch of radioactive microspheres was injected for measurements of regional myocardial blood flow. The LADCA was then occluded for 10 minutes and subsequently the myocardium reperfused for 30 minutes. This sequence of 10 minutes of occlusion and 30 minutes of reperfusion was then repeated. At the end of the second reperfusion period in 7 animals, 0.75 mg/kg EMD 60263 dissolved in 3 mL saline was infused over a period of 3 minutes. Fifteen minutes later, this was followed by a second dose of 1.5 mg/kg EMD 60263 dissolved in 6 mL saline and again infused over a period of 3 minutes. In 7 other animals, the same saline volumes were infused at similar time intervals. Systemic hemodynamic variables, segment length changes, and regional myocardial blood flows were determined at baseline, at the end of the second 30-minute reperfusion period (stunning), and 15 minutes after infusion of each dose of EMD 60263 or saline.
In five additional animals, the a-and 3-adrenergic receptors were blocked 15 minutes before administration of the first dose of EMD 60263 (ie, after 15 minutes of reperfusion following the second 10 minutes of occlusion). a-Adrenergic and 3-adrenergic receptor blockade was achieved with 1 mg/kg phentolamine and 0.5 mg/kg propranolol followed by an infusion of 0.5 mg/kg per hour, respectively.25 During the course of the experiments, it was found that EMD 60263 not only affected regional myocardial function but also exerted a pronounced bradycardic effect. To assess whether the bradycardia contributed to the changes in regional myocardial function, we performed another five experiments in which stunning was induced as described above, and 0.1 mg/kg of the specific negative chronotropic agent zatebradine (UL-FS 49)26,27 was administered intravenously at the end of the second 30-minute reperfusion period. At 15-minute intervals this was followed by doses of 0.2 and 0.5 mg/kg. In these experiments no radioactive microspheres were injected.
Data Analysis and Presentation
Systolic SLS was calculated from the tracings as 100%x (EDL-ESL)/EDL, in which EDL and ESL are the segment length at end-diastole and end-systole, respectively. These time points were defined as the opening and closing of the aortic valves, respectively. Left ventricular pressure and myocardial segment length were digitized (sample rate, 250 Hz) on a personal computer using an 8-bit analog-to-digital convertor. The area inside the left ventricular pressure-segment length loop was calculated and multiplied by 10 mm/EDLBaeiin. to arrive at a normalized index for EW.
Oxygen consumption of the myocardium perfused by the LADCA (MVo2) was calculated as the product of the local flow measurements in the animals without stunning) and the difference in the oxygen contents of the arterial and local coronary venous blood. 28 Mechanical efficiency was defined as the ratio of EW and MIVo2 (EW/MVo2 per beat). Because the index EW reflects external work but does not have its dimensions, we have expressed the changes in EW/MVo2 per beat as percentage change of baseline. The 14 animals were arbitrarily assigned to treatment with saline or EMD 60263 at the end of the second 30-minute period ("stunning"), and because no differences existed between the groups, the values of those groups obtained at baseline as well as those obtained at the end of the second 30-minute reperfusion period ("stunning") were pooled. Statistical significance of the changes induced by the stunning protocol were evaluated by Student's paired t test. The effects of EMD 60263 and saline during stunning were assessed by two-way ANOVA with repeated measures and Bonferroni adjustment (BMDP Statistical Software Inc). Statistical significance was accepted at a value of P<.05 (two-tailed). All data are presented as arithmetic mean±SEM. Drugs EMD 60263 (supplied by Prof Dr P. Schelling, E Merck, Darmstadt, Germany) was dissolved in saline to obtain infusion rates of 1 and 2 mL/min for the doses of 0.25 and 0.5 mg/kg per minute, respectively. Zatebradine (UL-FS 49) was a gift from Dr J. Dammgen (Dr Karl Thomae GmbH) and also dissolved in saline. Propranolol hydrochloride (ICI-Pharma) and phentolamine-methanosulfonide (CIBA-GEIGY) were also dissolved in saline.
Results
Effect of EMD 60263 in Anesthetized Pigs Systemic Hemodynamics
EMD 60263 infusion caused a slight decrease in mean arterial blood pressure (from 85 ± 1 to 78±3 mm Hg, P<.05), owing to a fall in diastolic arterial blood pressure (13±3%, P<.05) as systolic arterial blood pressure remained unchanged ( Table 1 ). The decrease in diastolic arterial blood pressure appeared to be secondary to a prolongation of the duration of diastole as heart rate decreased dose-dependently by as much as 37±3% from its baseline value of 118±5 beats per minute (P<.05). Cardiac output decreased as the increase in stroke volume (34±7%, P<.05) was not sufficient to compensate for the decrease in heart rate. LVdP/dtmax, left ventricular end-diastolic pressure, and systemic vascular resistance (calculated as the ratio of mean arterial blood pressure and cardiac output) were not affected.
Regional Myocardial Performance
EMD 60263 caused slight and similar increases (P<.05) in the systolic SLS in the distribution areas of both the LADCA (from 13±1% to 17±1%) and the LCXCA (from 13±1% to 17±2%) ( Table 2 ). Table 2 also shows that EW (EW per beat) also increased to the same extent in both areas (23±13% and 28±11% in the distribution areas of the LADCA and LCXCA, respectively). Taking into account the EMD 60263-induced decrease in heart rate, it can be calculated that EW per minute did not change.
EMD 60263 had no effect on oxygen extraction in the distribu'tion area of the LADCA and, because LADCA transmural myocardial blood flow (using the radioactive microsphere data in the animals with stunning and the Doppler blood flow did not change, no effect on MV02. Mechanical efficiency (EW/MVO2 per beat) was not affected after the lowest dose but tended to decrease after the highest dose of EMD 60263.
Effect of EMD 60263 in Anesthetized Pigs With Stunned Myocardium Systemic Hemodynamics
The two cycles of 10 minutes of coronary artery occlusion and 30 minutes of reperfusion caused a slight decrease in mean arterial blood pressure (from 91±2 to 86±2 mm Hg, P<.05), which was primarily caused by the fall in cardiac output from 2.64±0.15 to 2.30±0.06 L/min (P<.05) as systemic vascular resistance was only slightly increased (Table 3 ). Because heart rate was not affected, stroke volume fell in parallel with cardiac output. LVdP/dtmax was decreased by 19±3%, and left ventricular end-diastolic pressure was unchanged ( Table 3) .
Saline infusion after 30 minutes of reperfusion following the second 10 minutes of occlusion had no effect on any of the systemic hemodynamic variables. On the other hand, EMD 60263 administration resulted in dose-dependent decreases in mean arterial blood pressure, owing to a decrease in diastolic arterial blood pressure (by as much as 14±5%, P<.05), whereas systolic arterial blood pressure was unaffected ( Table  3 ). The decrease in diastolic arterial blood pressure again appeared to be secondary to a prolongation of the duration of diastole, as heart rate decreased dosedependently by as much as 28±3% (P<.05) after administration of the higher dose of EMD 60263. Stroke Systemic vascular resistance, LVdP/dtm., and left ventricular end-diastolic pressure also were not affected by EMD 60263 in this series of experiments. Regional Myocardial Segment Length Shortening During each of the two occlusions there was a complete loss of systolic SLS in the distribution area of the LADCA, whereas there was only a partial recovery during the subsequent reperfusion periods (from 16+1% at baseline to 8+1% at the end of the second reperfusion period). Fig 2 shows that in the animals treated with a saline infusion, SLS remained depressed. However, administration of EMD 60263 caused a dosedependent recovery of SLS to baseline levels.
Systolic SLS in the not-stunned (LCXCA-perfused) myocardium (15 +2% at baseline) did not change during the induction of stunning in the adjacent myocardium. Saline infusion had no effect on SLS of the not-stunned myocardium but increased to 18±2% after the highest dose of EMD 60263 (Fig 2) . This increment is similar to that observed in the animals that did not undergo the stunning protocol (Table 2) . Compared with the increase in the stunned myocardium, the effect in the not-stunned segment was much less. The latter was most clearly demonstrated by the ratio of SLSLADCA to SL&cxcA, which had decreased from 1.09±0.16 to 0.61±0.16 after induction of stunning. Although this ratio did not change during saline infusion, there was an increase to 0.75+±0.15 and 0.86+0.12 after 0.75 and 1.5 mg/kg EMD 60263, respectively (both P<.05 versus stunning).
External Work
The stunning protocol caused a decrease (P<.05) in EW per beat of the LADCA-perfused myocardium to different (P<.05) from saline-induced change from stunning at 49±5% of baseline (Figs 3 and 4) , and because heart rate did not change, there was a similar decrease (to 48±5% of baseline, P<.05) in EW per minute (data not shown). Saline infusion had no effect on EW per beat (Figs 3 and 4 ) and EW per minute of the stunned myocardium; however, after administration of EMD 60263, EW per beat increased dose-dependently to 89±4% of baseline after the highest dose (P<.05 versus stunning, Fig 4) , and EW per minute increased to only 63±5% of baseline because of the lower heart rate (P<.05 versus stunning, data not shown).
The stunning protocol caused minor decreases in both EW per beat (to 92±7% of baseline) and EW per minute (to 92±9% of baseline) of the not-stunned segment because of the decrease in left ventricular systolic pressure (Fig 4) . There were no further changes during saline infusion, but EW per beat increased to 105 ±5% of baseline after infusion of the highest dose of EMD 60263 (Fig 4) , and EW per minute further decreased to 75±7% of baseline (ie, 17±6% lower than the value observed during stunning, P<.05).
Because of the intravenous route of administration, EMD 60263 caused increases in EW performed by both the stunned and not-stunned segments, so we also calculated the ratio of the EW performed by the LADCA and EW performed by the LCXCA (EWLADcA/EWLcxcA) to assess whether differences in regional performance were attenuated after administration of EMD 60263. After the stunning protocol, this ratio was decreased from 1.24±0.13 to 0.70±0.12. Saline infusion did not affect this ratio, but after the first and second dose of EMD 60263, this ratio had increased to 0.94±0.24 and 1.02±0.21, respectively (both P<.05 versus stunning).
Regional Myocardial Blood Flow and Vascular Resistance
Thirty minutes after the second occlusion, transmural blood flow in the distribution area of the LADCA had decreased from 161±7 to 132±10 mL/min per 100 g (P<.05), a decrease that was equally distributed over the transmural layers, as the ratio of subendocardial to subepicardial blood flow (baseline value, 1.16 ±0.06) did not change. Neither saline infusion nor EMD 60263 infusion resulted in any significant changes. In the myocardium supplied by the LCXCA, transmural perfusion (baseline value, 179±9 mL/min per 100 g) and its distribution (baseline value of the ratio of subendocardial to subepicardial blood flow, 1.10±0.04) were unchanged after the occlusion-reperfusion sequences. Infusion of saline or EMD 60263 also did not affect perfusion of the not-stunned myocardium. Vascular resistance of the LADCA was increased from 0.58±0.03 to 0.69±0.04 mm Hg/(mL/min per 100 g) (P<.05) after the stunning protocol but did not change further during the subsequent infusion of saline or EMD 60263. The vascular resistance of the LCXCA was not affected by either the occlusion-reperfusion sequence or the subsequent infusion of saline or EMD 60263.
Regional Myocardial Oxygen Consumption
Oxygen saturation in the vein accompanying the LADCA (baseline, 24±2%) was unchanged (25±2%) after the two sequences of 10 minutes of occlusion and 30 minutes of reperfusion. From these data and the regional myocardial blood flow data, it follows that oxygen consumption of the stunned myocardium decreased from 452±21 to 378±30 mmol/min per 100 g (P<.05) before the infusion of saline or EMD 60263 was started. There was a similar decrease in MVo2 per beat, because heart rate was not affected. After administration of EMD 60263, coronary venous oxygen saturation was 29±4%, which was not significantly different from the value before administration. MVo2 was 380±35 and 338±34 mmol/min per 100 g after 0.75 and 1.5 mg/kg EMD 60263, respectively (both values, P<.05 versus MVo2 before the stunning value). MVo2 per beat was not significantly affected despite the decrease in heart rate. Because coronary venous oxygen saturation, myocardial blood flow, and heart rate did not change, MVo2 per minute and MVo2 per beat of the stunned myocardium remained unchanged during saline infusion.
Myocardial Efficiency of Regional Myocardium
In view of the large decrease in the EW index (to 49±5% of baseline) compared with the decrease in oxygen consumption per beat (to 86±6% of baseline), it follows that after stunning mechanical efficiency of the LADCA-perfused myocardium (EW/MVo2 per beat) was decreased to 59±8% of baseline (P<.05). Saline infusion had no effect on mechanical efficiency as both EW and MVo2 were unaltered (to 60±10% and 60±11% of baseline after the first and second infusion, respectively; both P<.05 versus baseline). Because EMD 60263 increased EW without an adverse effect on MVo2 per beat, the ratio of EW to MVo2 per beat had increased to 72±11% and 88±7% (P=NS versus baseline) after 0.75 and 1.5 mg/kg EMD 60263, respectively. Note that after the higher dose of EMD 60263, mechanical efficiency of the stunned myocardium was not different from the corresponding measurement in the animals without stunning.
In this series of experiments oxygen extraction of the not-stunned myocardium (distribution of the LCXCA) was not measured, so oxygen consumption of that segment therefore could not be determined. Because in the first series of experiments (pigs without stunning) EMD 60263 had no effect on myocardial oxygen extraction of control myocardium, we assumed that in the animals with stunned myocardium EMD 60263 also had no effect on oxygen extraction of the not-stunned myocardium. If true, the ratio of EW and transmural blood flow per beat also reflects mechanical efficiency. Fig 5 clearly shows that EMD 60263 had no significant effect on the ratio of EW and transmural blood flow per beat of the not-stunned myocardium.
Regional Blood Flows and Vascular Resistances
Blood flow and vascular resistance in a number of major organs (brain, kidneys, adrenals, and skeletal muscle) were not significantly affected by the induction of myocardial stunning. The subsequent saline infusion also did not lead to any significant changes. After EMD 60263, however, blood flow to the kidneys (by 12%, P<.05) and the muscular part of the diaphragm decreased. This was due to the decrease in mean arterial blood pressure, because vascular resistance of these organs was not affected (not shown). Effect of EMD 60263 in Anesthetized Pigs With Stunned Myocardium After a-and f3-Adrenergic Receptor Blockade Systemic Hemodynamics Blockade of the a-and f-adrenergic receptors, starting 15 minutes after the second 10-minute LADCA occlusion period, resulted in a pronounced depression of arterial blood pressure, cardiac output, heart rate, and LVdP/dtm,,. and an increase in left ventricular end-diastolic pressure, whereas stroke volume was only marginally affected (Table 4 ). However, in the presence of adrenergic receptor blockade, EMD 60263 caused changes in systemic hemodynamic variables similar to those in animals without adrenergic receptor blockade: dose-dependent decreases in mean and diastolic arterial blood pressures and heart rate, a dose-dependent increase in stroke volume, and no significant alterations in systolic arterial blood pressure, cardiac output, LVdP/ dtmax, and systemic vascular resistance (Table 4 ).
Regional Myocardial Performance
After adrenergic receptor blockade, SLS of the stunned myocardium decreased from 19±3% at baseline to 9+1%, and SLS of the not-stunned myocardium was not affected (baseline, 19±2%). In the presence of adrenergic receptor blockade, EMD 60263 caused a dose-dependent increase in SLS of the stunned myocardium to 20±2% after the highest dose (P<.05), an increase that is similar to the EMD 60263-induced increase, when the adrenergic receptors were not blocked (Fig 2) . In the not-stunned segment, SLS increased dose-dependently up to 23±2% after the last dose of EMD 60263. After adrenergic receptor blockade, EW of the stunned myocardium decreased to 44±11% of baseline values, and because of the fall in systolic arterial blood pressure, EW of the not-stunned segment decreased to 73 ± 12% of baseline (P< .05, Table 4 ). However, adrenergic receptor blockade did not affect the EMD 60263-induced effects on EW, as the increases (Table 3) were very similar to the EMD 60263-induced increases observed in the absence of adrenergic receptor blockade (Fig 3) . Effect of the Specific Bradycardic Agent Zatebradine (UL-FS 49) on the Function of Stunned Myocardium Table 5 shows that zatebradine in doses of 0.1 to 0.5 mg/kg lowered heart rate dose-dependently from 116±5 to 55±1 beats per minute. Similar to EMD 60263, there were dose-dependent decreases in mean and diastolic arterial blood pressures, whereas systolic arterial blood pressure was unchanged. Systolic SLS decreased from 17±2% at baseline to 9±1% at the end of the second reperfusion period. Lowering heart rate with zatebradine had no significant effect on systolic SLS of the stunned and not-stunned myocardium ( Table 5 ).
Discussion
Myocardial stunning is a transient event characterized by a depressed function and a relatively high oxygen consumption for the amount of work performed by the stunned myocardium. Several authors have shown that oxygen consumption of stunned myocardium is equal to or even exceeds that of normal myocardium,21,2229 although the latter is not a common finding.9'30 Still, there is a consensus that stunned myocardium uses oxygen less efficiently than normal myocardium.23 The mechanisms underlying the oxygen wastage (ie, decreased mechanical efficiency) of stunned myocardium are unknown, but it is unlikely that it is caused by mitochondrial uncoupling,31 an increase in basal metabolism,32 or changes in the Ca'+-ATPase activity of the sarcoplasmic reticulum.10,33 We have reported previously that in the same model as used in the present study, the calcium-sequestering properties of the sarcoplasmic reticulum were unchanged during stunning.8 It is therefore most likely that an inefficient utilization of ATP by the contractile apparatus is a major factor contributing to the oxygen wastage. A decrease in the sensitivity of the contractile regulatory proteins to calcium and the consequent changes in the myosin ATPase activity could explain a decrease in the ratio of EW to oxygen consumption and the depressed contractile function of stunned myocardium. Therefore, the aim of the present study was to elucidate whether in in vivo experiments the calcium-sensitizing actions of EMD 60263 could restore function as well as mechanical efficiency of stunned myocardium. Traditionally, the not-stunned myocardium adjacent to the stunned myo- cardium serves as a control segment. However, one cannot exclude the possibility that the response of the not-stunned segment is affected by the alterations in the adjacent stunned myocardium. For instance, in porcine myocardium it has been shown that phosphorylation of phospholamban is affected when the adjacent myocardium is exposed to a prolonged period of ischemia. 34 We therefore performed a series of experiments in which the effect of EMD 60263 was studied in pigs that had not undergone the stunning protocol. The results in Tables 1 and 3 show that the responses of the systemic hemodynamic variables were very similar in both models. The results presented in Table 2 show that in the distribution area of the LADCA, EMD 60263 slightly increased SLS and EW per beat but had no effect on LADCA blood flow and oxygen extraction in that segment of the myocardium. Consequently, oxygen consumption was unchanged, as was mechanical efficiency (85+± 13% of baseline after the higher dose of EMD 60263). Recruitment of inotropic reserve in stunned myocardium has been accomplished by stimulation with adrenergic receptor agonists such as dopamine and epinephrine,35-37 calcium,38 and by post-extrasystolic potentiation.39 In addition to inotropic stimulation it is also possible to enhance the function of stunned myocardium by increasing myocardial blood flow with vasodilators such as dipyridamole, papaverine, and nitroglycerine. 29 In the present study, we showed that EMD 60263 increased systolic SLS of both the stunned and not-stunned porcine myocardium. The data presented in Fig 2 also demonstrated that the effect on the stunned myocardium was much more pronounced than on the not-stunned myocardium and that differences in performance between the two areas were almost abolished. Comparison of the data presented in Table 2 and Fig 2 also shows that the effects of EMD 60263 on wall function and EW in the animals with and without myocardial stunning were very similar to those observed in the not-stunned myocardium (distribution area of the LCXCA). This action of EMD 60263 was not attenuated when experiments were repeated after a-and 3-adrenergic receptor blockade, thereby excluding adrenergic stimulation and phosphodiesterase inhibi-tion40-42 as the cause of the positive inotropic action of EMD 60263. Furthermore, EMD 60263 did not increase coronary blood flow, eliminating coronary vasodilation as a potential factor to the inotropic effects of EMD on postischemic function by administering the specific 60263. A complicating factor in the present study was negative chronotropic agent zatebradine and found that the lowering of heart rate by EMD 60263, as several we could not restore function when we lowered the groups of investigators have shown that bradycardia heart rate over an even wider range than with EMD improves contractile function of ischemic myocardi-60263. Hence, we may conclude that the EMD 60263um.2643 However, the effect of bradycardia on the induced bradycardia does not play an important role in function of postischemic myocardium is not well docuthe improvement in function. Finally, because in vitro mented. We therefore studied the effect of bradycardia experiments have shown a negative inotropic effect of tZatebradine-induced change from stunning is significantly different (P<.05) from saline-induced change from stunning. the enantiomer EMD 60264, it is most likely that EMD 60263 exerted its effect by increasing the sensitivity of the contractile proteins to calcium. At first glance, our results appear to be in contrast with those reported by Heusch et al,1" who reported that the increases in systolic wall thickening were very similar for notstunned and stunned myocardium after administration of AR-L 57. However, it must be kept in mind that this drug increases myocardial contractility predominantly by phosphodiesterase inhibition.12 The fact that in the present study EMD 60263 exhibited no vasodilator properties in the systemic vascular bed or a number of regional vascular beds, a usual finding for calcium sensitizers with phosphodiesterase inhibitor activity, is also in agreement with the in vitro studies, which showed that EMD 60263 is almost completely devoid of any phosphodiesterase inhibitor activity.
Parallel to the decreases after stunning and increases after EMD 60263 in systolic SLS, we found decreases and increases in EW. This is not surprising because the former is derived from the relation between the changes in segment length and left ventricular pressure. When we related EW to the MVo2 per beat, we confirmed the decrease in mechanical efficiency of stunned myocardium. 23 However, a striking finding in the present study is that this decrease in mechanical efficiency for stunned segment could be reversed with EMD 60263. This action of EMD 60263 appears to be specific for stunned myocardium, as EMD 60263 had no effect on mechanical efficiency of the same myocardial segment when it was administered in the pigs without stunning ( Table 2) . These data provide strong support for the hypothesis that calcium desensitization plays a role in the relative oxygen wastage of stunned myocardium. Gross et al44 have also shown a beneficial effect of the thiadiazinone derivative EMD 57033 on bioenergetics of skinned ventricular trabeculae. On the other hand, no beneficial effects on bioenergetics were observed in isolated heart studies using EMD 5399845 and pimobendan.46 These two studies4546 do not necessarily contradict the present results, as we found an effect of EMD 60263 on mechanical efficiency only of stunned ( Fig 5) and not of normal myocardium (Table 2 ).
In neither of the two series of experiments with EMD 60263 did the global contractility index, LVdP/dtma., increase, although both SLS and stroke volume increased. A number of factors could explain this observation, as LVdP/dtma,, in addition to myocardial contractility, also depends on heart rate and loading conditions of the heart. We have shown that in anesthetized pigs with normal hearts, LVdP/dt.ma. increases markedly when heart rate is raised from 60 to 100 beats per minute.47 In this respect, lowering heart rate should induce a decrease in LVdP/dtma,. It thus could be argued that the positive inotropic effects of EMD 60263 counteracted a possible negative effect of the bradycardia on LVdP/dt ma,. Nevertheless, administration of zatebradine, which is devoid of inotropic actions,48 did not improve regional function of the stunned myocardium (Table 5 ) and did not lead to a decrease in LVdP/dt.,,.
It is feasible that an intracoronary administration using much lower doses of EMD 60263 would have provided an improvement in regional function without pronounced global hemodynamic effects.
The absence of an increase in LVdP/dt ma. can also be explained by intracellular changes in Ca'+ handling induced by the Ca2`-sensitizing properties of EMD 60263. Lee and Allen49 have shown that increasing Ca'+ sensitivity, and thereby increasing the troponin binding constant for Ca2`, causes a slower release of Ca`from troponin and hence a prolonged time course of tension. This implies that Ca'2 remains bound longer to troponin, and since the sarcoplasmic reticulum function in our experimental model is not impaired,8 a decreased Ca 2 transient might result.49 These effects can counteract each other, leading to an unchanged LVdP/dt ma,.
From the finding that the effects of the Ca 2 sensitizer EMD 60263 are more pronounced in stunned myocardium than in not-stunned myocardium, we conclude that Ca 2+ desensitization may play a role in the events leading to postischemic myocardial dysfunction and oxygen wastage.
